Dermatomyositis Clinical Trials Dermatomyositis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis
Condition:   Dermatomyositis Intervention:   Drug: Lenalidomide Sponsor:   Jiangxi Provincial People's Hopital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2022 Category: Research Source Type: clinical trials